Weighted Average Number of Shares Outstanding, Basic of DICE Therapeutics, Inc. from 30 Jun 2021 to 30 Jun 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
DICE Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2021 to 30 Jun 2023.
  • DICE Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2023 was 47,310,035, a 27% increase year-over-year.
  • DICE Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 39,401,106, a 218% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

DICE Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 47,310,035 +9,947,320 +27% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 47,193,122 +9,931,437 +27% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 39,401,106 01 Oct 2022 31 Dec 2022 10-K 15 Mar 2023 2022 Q4
Q3 2022 37,480,179 +29,929,051 +396% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 37,362,715 +35,114,028 +1562% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 37,261,685 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q3 2021 7,551,128 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 2,248,687 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2

DICE Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 39,401,106 +27,017,091 +218% 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2023 2022 FY
2021 12,384,015 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.